The FDA is considering Pfizer/BioNTech’s request for its updated COVID-19 booster; California Governor Gavin Newsom rejects bill allowing supervised injection sites; a new report from the CDC shows 2019-2020 life expectancy fell in all states.
An updated booster that targets the BA.4 and BA.5 Omicron subvariants of SARS-CoV-2 is under consideration by the FDA for use in patients 12 years and older, reports Stat News. Pfizer and BioNTech applied for emergency use authorization (EUA) of their newest booster, despite not including new clinical trial data—one is expected to start this month—with this most recent application. According to a statement from Pfizer, a conditional marketing authorization application has also been submitted to the European Medicines Agency for the booster, which contains mRNA encoding both the original SARS-CoV-2 and Omicron BA.4/BA.5 spike proteins.
Driven in large part by the ongoing opioid crisis and presented as a harm reduction measure, a bill has been rejected by California Governor Gavin Newsom that would have permitted injection drug use under supervised watch, reports The New York Times. The proposed pilot program included providing clean needles and connections to treatment services. Proponents say this program had potential to save taxpayer money and thousands of lives, while detractors claim illicit drug use would be encouraged and treatment discouraged.
According to a new report from the CDC on life expectancy in all states and Washington, DC, life expectancy dropped by 1.8 years to 77.0 years overall from 2019 to 2020. This is the last year for which complete data are available, according to ABC News, with principal reasons for the decline being COVID-19 and drug overdoses. Women had an overall life expectancy more than 5 years longer than that of men, at 79.9 vs 74.2 years, and among the states, Hawaii had the highest overall life expectancy at 80.7 years and Mississippi the lowest, at 71.9 years.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More
Study Validates Smartphone Analysis for Predicting Obstructive Sleep Apnea
November 29th 2023Findings show breathing sounds recorded by smartphones during sleep at home can reliably identify obstructive sleep apnea, presenting an innovative and accessible alternative to traditional in-laboratory polysomnography.
Read More